Skip to main content
SpringerLink
Log in

Presentation and Natural Course of Ulcerative Colitis

  • Chapter
Ulcerative Colitis

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 1764 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Latella G, Papi C (2012) Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol 18(29):3790–3799

    Article  Google Scholar 

  2. Burisch J, Pedersen N, Čuković-Čavka S et al (2914) East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 63(4):588–597

    Article  Google Scholar 

  3. Farmer RG, Easley KA, Rankin GB (1993) Clinical patterns, natural history, and progression of ulcerative colitis: a long-term follow-up of 1116 patients. Dig Dis Sci 38(6): 1137–1146

    Article  CAS  Google Scholar 

  4. Magro F, Gionchetti P, Eliakim R et al; European Crohn’s and Colitis Organisation [ECCO] (2017) Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis 11(6):649–670

    PubMed  Google Scholar 

  5. Sands BE (2015) Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology 149(5):1275–1285

    Article  CAS  Google Scholar 

  6. Loftus EV Jr, Silverstein MD, Sandborn WJ et al (2000) Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut 46(3):336–343

    Article  Google Scholar 

  7. Vegh Z, Burisch J, Pedersen N et al (2014) Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J Crohns Colitis 8(11):1506–1515

    Article  CAS  Google Scholar 

  8. Hammer T, Nielsen KR, Munkholm P et al (2016) The Faroese IBD Study: incidence of inflammatory bowel diseases across 54 years of population–based data. J Crohns Colitis 10(8):934–942

    Article  Google Scholar 

  9. Loftus EV Jr, Sandborn WJ (2002) Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31(1):1–20

    Article  Google Scholar 

  10. Birkenfeld S, Zvidi I, Hazazi R, Niv Y (2009) The prevalence of ulcerative colitis in Israel: a twenty-year survey. J Clin Gastroenterol 43(8):743–746

    Article  Google Scholar 

  11. Orholm M, Munkholm P, Langholz E et al (1991) Familial occurrence of inflammatory bowel disease. N Engl J Med 324(2):84–88

    Article  CAS  Google Scholar 

  12. Mahid SS, Minor KS, Soto RE et al (2006) Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 81(11):1462–1471

    Article  Google Scholar 

  13. Beaugerie L, Massot N, Carbonnel F et al (2001) Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 96(7):2113–2116

    Article  CAS  Google Scholar 

  14. Andersson RE, Olaison G, Tysk C, Ekbom A (2001) Appendectomy and protection against ulcerative colitis. N Engl J Med 344(11):808–814

    Article  CAS  Google Scholar 

  15. Koutroubakis IE, Vlachonikolis IG (2000) Appendectomy and the development of ulcerative colitis: results of a meta-analysis of published case-control studies. Am J Gastroenterol 95(1):171–176

    Article  CAS  Google Scholar 

  16. Klement E, Cohen RV, Boxman J et al (2004) Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr 80(5):1342–1352

    Article  CAS  Google Scholar 

  17. Anderson CA, Boucher G, Lees CW et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43(3):246–252

    Article  CAS  Google Scholar 

  18. Heller F, Florian P, Bojarski C et al (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129(2):550–564

    Article  CAS  Google Scholar 

  19. Frank DN, Robertson CE, Hamm CM et al (2011) Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 17(1):179–184

    Article  Google Scholar 

  20. Heller F, Fromm A, Gitter AH et al (2008) Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function. Mucosal Immunol 1(Suppl 1):S58–S61

    Article  CAS  Google Scholar 

  21. Steel AW, Mela CM, Lindsay JO et al (2011) Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment. Aliment Pharmacol Ther 33(1):115–126

    Article  CAS  Google Scholar 

  22. Briskin M, Winsor-Hines D, Shyjan A et al (1997) Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 151(1):97–110

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Masuda H, Iwai S, Tanaka T, Hayakawa S (1995) Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase. J Clin Lab Immunol 46(3):111–123

    CAS  PubMed  Google Scholar 

  24. Silverberg MS, Satsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5A–36A

    Article  Google Scholar 

  25. Duricova D, Burisch J, Jess T et al; ECCO-EpiCom (2014) Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis 8(11):1351–1361

    PubMed  Google Scholar 

  26. Gower-Rousseau C, Dauchet L, Vernier-Massouille G et al (2009) The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol 104(8):2080–2088

    Article  Google Scholar 

  27. Langholz E, Munkholm P, Krasilnikoff PA, Binder V (1997) Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 32(2):139–147

    CAS  Google Scholar 

  28. Magro F, Rodrigues A, Vieira AI et al (2012) Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflamm Bowel Dis 18(3):573–583

    Article  Google Scholar 

  29. Hoie O, Wolters FL, Riis L et al; European Collaborative Study Group of Inflammatory Bowel Disease (2007) Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 132(2):507–515

    Google Scholar 

  30. Jess T, Loftus EV Jr, Velayos FS et al (2006) Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology 130(4):1039–1046

    Article  Google Scholar 

  31. Reinisch W, Sandborn WJ, Rutgeerts P et al (2012) Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and ACT-2 extension studies. Inflamm Bowel Dis 18(2):201–211

    Article  Google Scholar 

  32. Rutgeers P, Sandborn WJ, Feagan BG et al (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353(23):2462–2476

    Article  Google Scholar 

  33. Jess T, Gamborg M, Munkholm P, Sørensen TI (2007) Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 102(3):609–617

    Article  Google Scholar 

  34. Harbord M, Annese V, Vavricka SR et al; European Crohn’s and Colitis Organisation [ECCO] (2016) ECCO Guideline/Consensus Paper. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis 10(3):239–254

    Google Scholar 

  35. Lutgens MW, van Oijen MG, van der Heijden GJ et al (2013) Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 19(4):789–799

    Article  Google Scholar 

  36. Annese V, Beaugerie L, Egan L et al; European Crohn’s and Colitis Organisation [ECCO] (2015) European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. J Crohns Colitis 9(11):945–965

    PubMed  Google Scholar 

  37. Watanabe T, Konishi T, Kishimoto J et al (2011) Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis 17(3):802–808

    Article  Google Scholar 

  38. Hrabe JE, Byrn JC, Button AM et al (2014) A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome. J Surg Oncol 109(2):117–121

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical and Surgical Sciences, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy

    Nicola Renzi

Authors
  1. Gilberto Poggioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicola Renzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicola Renzi .

Editor information

Editors and Affiliations

  1. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

    Gilberto Poggioli

  2. General Surgery Unit, Department of Digestive Diseases, S. Orsola-Malpighi Hospital, Bologna, Italy

    Gilberto Poggioli

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag Italia

About this chapter

Cite this chapter

Poggioli, G., Renzi, N. (2019). Presentation and Natural Course of Ulcerative Colitis. In: Poggioli, G. (eds) Ulcerative Colitis. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-3977-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-3977-3_2

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-3976-6

  • Online ISBN: 978-88-470-3977-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation